title: HLA-A2 and B35 are strong predictors of responsiveness to clozapine: preliminary data in Italian schizophrenia patients.
authors.forename: M
authors.initials: M
authors.lastname: Marchini
authors.forename: R
authors.initials: R
authors.lastname: Scorza
authors.forename: R
authors.initials: R
authors.lastname: Antonioli
authors.forename: S
authors.initials: S
authors.lastname: Scarone
authors.forename: B
authors.initials: B
authors.lastname: Grassi
authors.forename: M
authors.initials: M
authors.lastname: Epifani
authors.forename: C
authors.initials: C
authors.lastname: Dragoni
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D003024:Clozapine / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D015789:HLA-A2 Antigen / Q000378:metabolism*; D015797:HLA-B35 Antigen / Q000378:metabolism*; D006801:Humans; D007558:Italy; D008297:Male; D012559:Schizophrenia / Q000175:diagnosis / Q000188:drug therapy* / Q000378:metabolism*; D012680:Sensitivity and Specificity; D016896:Treatment Outcome
chemical_list: D014150:Antipsychotic Agents; D015789:HLA-A2 Antigen; D015797:HLA-B35 Antigen; D003024:Clozapine